| Principal Investigator | Title | Department |
| Chew, Helen | A Randomized Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor-Induced Musculoskeletal Pain and Stiffness in Women with Early Stage Breast Cancer, Phase III | Cancer Center |
| Anderson, Ivan | Markers of Autonomic Tone and Physical Activity Prescription, A Randomized Control Trial | UC Davis |
| Semrad, Thomas | A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3
Trial of E7080 in 131I-Refractory Differentiated Thyroid Cancer | Cancer Center |
| Agius, Mark | A Phase II, Randomized, double-blind, parallel-group, placebo-controlled, multi-center study to evaluate the safety and efficacy of abatacept in adults with relapsing-remitting multiple sclerosis (ACCLAIM STUDY). | UC Davis |
| Apperson, Michelle | A Randomized, Double-blind, Double-Dummy, Parallel-Group study to Evaluate the efficacy and safety of Ocrelizumab in comparison to Interferon Beta-1a (Rebif) in patients with Relapsing Multiple Sclerosis
| UC Davis |
| Richman, Carol | A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications | Cancer Center |
| Kelly, Karen | UC Davis, Lung Cancer Research Program (LCRP) Biospecimen Collections: 'At Risk' Specimen Collection and Banking Protocol | Cancer Center |
| Fragoso, Ruben | A Phase II Trial of Hippocampal Avoidance During Whole-Brain Radiotherapy for Brain Metastases | Cancer Center |
| Evans, Christopher | PREVAIL: A Multinational Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Oral MDV3100 in Chemotherapy-Naïve Patients with Progressive Metastatic Prostate Cancer Who Have Failed Androgen Deprivation Therapy | Cancer Center |
| Raff, Gary | SHRINERS: Magnetic Mini-Mover Device to Correct Pectus Excavatum | UC Davis |
| Howell, Lydia | Davis Breast Research Program/ATHENA Breast Health Network | Cancer Center |
| Yang, Kai | High Resolution Three-Dimensional Computed Tomography (CT) Imaging of Specimens to Reduce Lumpectomy Re-Exicion Rates | Cancer Center |
| Leiserowitz, Gary | Clinical Protocol to Evaluate Glycans Analysis As a Diagnostic Test for Ovarian Cancer | Cancer Center |
| Semrad, Thomas | A Phase II Study of MK-2206 in Patients with Advanced Hepatocellular Carcinoma Who Have Failed or Are Intolerant of One Prior Line of Anti-Angiogenic Therapy (NCI#8752) | Cancer Center |
| Lara, Primo | EVEREST: EVErolimus for Renal Cancer Ensuing Surgical Therapy, A Phase III Study | Cancer Center |
| Agius, Mark | A Phase llI, Multicenter, Randomized, Parallel-Group, Double Blinded, Placebo Controlled Study to Evaluate the Efficacy and Safety of Ocrelizumab in Adults with Primary Progressive Multiple Sclerosis [Protocol #WA25046/B Version Date: 03 March 2011] | UC Davis |
| Pan, Chong-Xian | An Open-Label, Multicenter, Randomized Phase 2 Study Evaluating the Safety and Efficacy of Docetaxel in Combination with Ramucirumab (IMC-1121B) Drug Product or IMC-18F1 or Without Investigational Therapy as Second-line Therapy in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Bladder, Urethra, Ureter, or Renal Pelvis Following Disease Progression on First-line Platinum-based Therapy | Cancer Center |
| Fragoso, Ruben | Phase III Study of Radiation Therapy with or without Temozolomide for Symptomatic or Progressive Low-Grade Gliomas | Cancer Center |
| Lara, Primo | CCRC: Phase II Trial of the Akt inhibitor MK-2206 plus Erlotinib (OSI-774) in Patients with Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response (including Stable Disease) with Erlotinib Therapy (NCI #8698) | Cancer Center |
| Gandara, David | A Open-Label, Phase I/Ib Dose Escalation Study to Assess the Safety and Tolerability of GSK1120212 in Combination with Docetaxel, Erlotinib, Pemetrexed, Pemetrexed + Carboplatin, or nab-Paclitaxel in Subjects with Advanced Solid Tumors | Cancer Center |
| Semrad, Thomas | CCRC: Phase I Pharmacokinetic Study of Belinostat for Solid Tumors and Lymphomas in Patients with Varying Degrees of Hepatic Dysfunction (NCI#8846) | Cancer Center |
| Martinez, Steve | Tumescent Mastectomy: A Prospective Comparison to Standard Mastectomy Technique | Cancer Center |
| Chew, Helen | Phase II Study of 5-Azacitidine and Entinostat (SNDX-275) in Patients with Advanced Breast Cancer (NCI#8822) | Cancer Center |
| Ducore, Jonathan | A Group Wide Protocol for Collecting and Banking Pediatric Cancer Research Specimens - An IRS Protocol | Cancer Center |
| Chew, Helen | A Pilot and Phase II Study of Entinostat and Anastrozole in Postmenopausal Women with Operable Triple Negative Breast Cancer to Evaluate Biomarkers and Surrogates for Response (NCI#8597) | Cancer Center |
For Investigators